Blood Pump Articles & Analysis
26 news found
Digoxin is used primarily to improve the heart’s ability to pump blood in patients with congestive heart failure (CHF) and to treat problems such as high blood pressure. ...
The analysis of four dimensional SQuEEZ parameters has the potential to improve the ability to quantify accurately the regional myocardial contractile function (ability of the heart to pump blood) through the heart muscle of the left ...
About Heart Failure Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. In the US. heart failure is estimated to affect 6.9 million adults and is expected to increase by 24% to nearly 8.5 million in 2030. ...
ByCVRx
The analysis of SQuEEZ parameters has the potential to improve the ability to quantify accurately the ability of the heart to pump blood through the left ventricle. Cardiac CT combined with SQuEEZ analysis software can provide clinicians with a normalized measurement to determine the answer to the first and most important clinical question a cardiac surgeon ...
Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. Barostim works by stimulating baroreceptors - natural sensors in the body that tell the nervous system how to regulate heart, kidney and vascular function. These effects reduce the heart's ...
ByCVRx
Additionally, pVADs are used to treat patients suffering from cardiogenic shock (CS), a condition that can occur following a severe heart attack, and is associated with a high rate of morbidity as a patient’s heart is suddenly too weak to adequately pump blood to vital organs. “Temporary mechanical support enables a high-risk patient to undergo ...
As a result, the heart muscle’s ability to pump blood is reduced, which can lead to an irregular heart rhythm, the backup of blood into the lungs or rest of the body, and death. ...
The innovative design uses intra-aortic placement and harnesses fluid entrainment to pump blood without valves and allows for physiologically natural delivery of therapy. Use of the system can easily integrate into practices as the pump can be deployed in less than 10 minutes and device operation does not require large or expensive capital ...
The WiSE (Wireless Stimulation Endocardially) CRT System is designed to improve the heart’s pumping ability by synchronizing the left and right ventricles to distribute blood to the lungs and body more effectively. ...
The EXCOR® Graft Cannula* connects the outflow side of the blood pump to the ascending aorta for left ventricular support or to the pulmonary artery for right ventricular support. ...
Scott has more than two decades of experience in the medical technology industry, including with prosthetic heart valves, heart valve repair, orthopedic surgery, stents, blood pumps, TETS, robotic prostheses / orthoses and many more. His work in this industry has included countless IP diligence evaluations in the contexts of IPOs, strategic acquisitions and ...
As a result, the heart muscle’s ability to pump blood is reduced, which can lead to an irregular heart rhythm, the backup of blood into the lungs or rest of the body, and death. ...
The procedure was performed safely and easily due to the pump’s position in the aorta versus the heart, which allowed for rapid deployment of the catheter-based pump and significantly reduced the risk of stroke and damage to the heart,” stated Dr. ...
CorWave is developing an implantable LVAD based on a breakthrough technology, the wave membrane pump. The membrane technology enables the CorWave blood pump to have a wide range of flow conditions, gentle blood propulsion, and to generate physiologic pulsatility, all of which are required to help reduce the adverse events ...
ByCorWave
” About Heart Failure and Cardiac Resynchronization Therapy (CRT) Heart failure is a serious condition in which the heart is unable to pump enough blood to meet the body’s demands. A progressive, debilitating disease, heart failure often occurs when electrical signals within the heart are disrupted, causing the heart’s ventricles to beat in an ...
FMR is due to the mitral valve not closing tightly, resulting in blood flowing or leaking backwards through the mitral valve. This further decreases the amount of oxygenated blood that is pumped out to the body, increases the symptoms associated with heart failure, and decreases the quality of life of those who have been diagnosed. ...
CorWave has achieved two critical technical milestones required to proceed to the clinical phase: a successful 60-day in vivo implant, with excellent hemocompatibility results2 , and the completion of 6-month real-time durability tests of the pump. Professor André Vincentelli, MD, Head of the Mechanical Circulatory Support and Transplantation Program at Lille University ...
ByCorWave
The foundation of our next generation system is an integrated artificial lung cartridge/blood pump that will be unparalleled in the industry as the most efficient carbon dioxide removal and oxygen delivery system, which will address the needs of acute respiratory failure patients that require ECCO2R and/or ECMO (extracorporeal membrane oxygenation). ...
Additionally, pVADs are used to treat patients suffering from cardiogenic shock (CS), a condition that can occur following a severe heart attack, and is associated with a high rate of morbidity as a patient’s heart is suddenly too weak to adequately pump blood to vital organs. “Temporary mechanical support provides many patients with the option to ...
” “The AccuCinch device is designed to provide structural support to the heart wall so it maintains its ability to pump blood in an efficient manner, providing patients with a new option for improving heart function,” said Azeem Latib, MD, co-principal investigator of the CorCinch HFrEF study and medical director of Structural Heart ...